Home › NDC Lookup › Ingredients › Bismuth Subsalicylate › 58933-0017-24
POCKET PEPTO Pepto Bismol Bismuth subsalicylate 262 mg Tablet — NDC 58933-0017-24 package photo

POCKET PEPTO Pepto Bismol Bismuth subsalicylate 262 mg Tablet

by Procter & Gamble Manufactura S de RL de CV · 2 VIAL, PLASTIC in 1 CARTON (58933-017-24) / 12 TABLET in 1 VIAL, PLASTIC
NDC 58933-0017-24
🏷️ FDA NDC (as labeled) 58933-017-24 billing pads the product segment with a zero
This package
Contains12 tablet in 1 vial, plastic Pack sizes2 compare ↓
Also comes in: 12 tablets 58933-0017-12
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 58933-017-24
Product NDC 58933-017
11-digit billing NDC 58933001724
RxCUI 308760
UNII 62TEY51RR1
UPC 0301490000106
Application # M008
SPL Set ID 0429d816-f3a9-2076-e063-6394a90aef21
Established class (EPC) Bismuth
Chemical class Bismuth
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-06-01
Route ORAL
Dosage form TABLET
Substance BISMUTH SUBSALICYLATE
Why two NDCs? The FDA registers this code as 58933-017-24 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 58933-0017-24. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Bismuth class.

Pharmacologic class Bismuth
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerProcter & Gamble Manufactura S de RL de CV
FDA applicationM008 (OTC MONOGRAPH DRUG)
Labeler code58933
First marketedJun 2019
Product typeHuman Otc Drug
Portfolio17 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • It's used to relieve diarrhea — including traveler's diarrhea — and upset stomach symptoms that come from overdoing it on food or drink. That includes heartburn, indigestion, nause...
  • What exactly is bismuth subsalicylate used for?
  • A dark or black stool — and sometimes a darkened tongue — is a well-known, harmless side effect of bismuth subsalicylate. It's just the way the medicine reacts in your digestive tr...
  • Why did my stool turn black after taking this? Should I be worried?
📖 Read our full Bismuth Subsalicylate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GNP Pink Bismuth 262 mg 24385-0017-58 Amerisource 40 tablets $0.093 — Availability likely —
Bismuth Subsalicylate 262 mg 70000-0594-01 LEADER/ 24 tablets $0.093 — Availability likely —
Foster and Thrive Stomach Relief 262 mg 70677-1082-01 Strategic 40 tablets $0.093 — Availability likely —
Stomach Relief 262 mg 83324-0060-40 Chain 40 tablets $0.093 — Availability likely —
Walgreen 262 mg 00363-9125-40 WALGREEN 40 tablets — — FDA listed —
up and up 5-symptom digestive relief 262 mg 11673-0122-48 Target 48 tablets — — FDA listed —
up and up 5-symptom digestive relief 262 mg 11673-0125-20 Target 40 tablets — — FDA listed —
5-Symptom Digestive Relief 262 mg 11673-0880-44 TARGET 40 tablets — — FDA listed —
Rite Aid Digestive Relief 262 mg 11822-1254-00 RITE 40 tablets — — FDA listed —
Digestive Relief 262 mg 21130-0125-40 SAFEWAY 40 tablets — — FDA listed —
Kroger Digestive Relief 262 mg 30142-0524-24 KROGER 24 tablets — — FDA listed —
Topco Stomach Relief 262 mg 36800-0104-28 Topco 40 tablets — — FDA listed —
Stomach Relief 262 mg 37808-0346-08 H 24 tablets — — FDA listed —
Equaline Stomach Relief 262 mg 41163-0123-28 UNITED 40 tablets — — FDA listed —
meijer stomach relief 262 mg 41250-0324-40 Meijer 40 tablets — — FDA listed —
Stomach reliever 262 mg 42507-0707-28 Hyvee 40 tablets — — FDA listed —
Stomach Relief 262 mg 49035-0346-10 Wal-Mart 40 tablets — — FDA listed —
Kaopectate 262 mg 55505-0197-07 Kramer 28 tablets — — FDA listed —
POCKET PEPTO Pepto Bismol 262 mgthis 58933-0017-24 Procter 12 tablets — — FDA listed —
Pepto-Bismol 262 mg 58933-0476-01 Procter 2 tablets — — FDA listed —
QC Pink Bismuth 262 mg 63868-0171-40 QUALITY 40 tablets — — FDA listed —
Stomach Relief 262 mg 63868-0691-40 CHAIN 40 tablets — — Discontinued —
Anti-Diarrheal 262 mg 66715-6841-04 Lil' 24 tablets — — FDA listed —
Stomach relief 262 mg 69842-0172-12 CVS 24 tablets — — FDA listed —
Bismuth Subsalicylate 262 mg 69842-0346-12 CVS 24 tablets — — FDA listed —
AMAZON Digestive Relief 262 mg 72288-0125-40 AMAZON.COM 40 tablets — — FDA listed —
Pepto-Bismol 262 mg 76420-0490-24 ASCLEMED 24 tablets — — FDA listed —
Stomach Relief 262 mg 63868-0622-30 CDMA- 30 tablets — — FDA listed —
Topcare Stomach Relief Original Strength 262 mg 76162-0001-85 TopCo 30 tablets — — FDA listed —
CVS Stomach Relief 262 mg 51316-0124-48 CVS 48 tablets — — FDA listed —
Bismuth 262 mg 69168-0046-69 Allegiant 12 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2019
On the market since
Jun 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
58933-0017-12 1 VIAL, PLASTIC in 1 CARTON (58933-017-12) / 12 TABLET in 1 VIAL, PLASTIC 2019-06-01 Active
58933-0017-24 You're viewing this 2 VIAL, PLASTIC in 1 CARTON (58933-017-24) / 12 TABLET in 1 VIAL, PLASTIC 2019-06-01 Active

Pack size FAQ

What quantity is in NDC 58933-0017-24?
NDC 58933-0017-24 is listed by the FDA — 2 vial, plastic in 1 carton / 12 tablet in 1 vial, plastic.
What NDC number is used to bill for this package of POCKET PEPTO Pepto Bismol Bismuth subsalicylate 262 mg Tablet?
Bill NDC 58933-0017-24 — the 11-digit billing format is 58933001724. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 58933-017-24, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 58933-0017-24, written without dashes as 58933001724. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 58933-0017-24, the first segment (58933) is the labeler code FDA assigned to Procter & Gamble Manufactura S de RL de CV; the middle segment (0017) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (24) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Procter & Gamble Manufactura S de RL de CV. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 12 tablets (58933-0017-12). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Procter & Gamble Manufactura S de RL de CV is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 21 words ▾

Uses relieves travelers' diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness

⏱️ Dosage and Administration 86 words ▾

Directions chew or dissolve in mouth adults and children 12 years and over: 2 tablets (1 dose) every 1/2 hour or 4 tablets (2 doses) every hour as needed for diarrhea 2 tablets (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea) do not exceed 8 doses (16 tablets) in 24 hours use until diarrhea stops but not more than 2 days children under 12 years: ask a doctor drink plenty of clear fluids to help prevent dehydration caused by diarrhea

⚠️ Warnings 75 words ▾

Warnings Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness. Allergy alert: Contains salicylate.

Do not take if you are • allergic to salicylates (including aspirin) • taking other salicylate products

🆘 Overdosage 15 words ▾

In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 23 words ▾

Other information each tablet contains: calcium 140 mg, magnesium 9 mg salicylate 99 mg low sodium avoid excessive heat (over 104°F or 40°C)

🧪 Active Ingredient 9 words ▾

Active ingredient (in each tablet) Bismuth subsalicylate 262 mg

🧪 Inactive Ingredients 26 words ▾

Inactive ingredients adipic acid, calcium carbonate, D&C Red No. 27 aluminum lake, FD&C Red No. 40 aluminum lake, flavor, magnesium stearate, mannitol, povidone, saccharin sodium, talc

🎯 Purpose 6 words ▾

Purpose Upset stomach reliever and antidiarrheal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 58933-0013-02 · Procter 58933-0020-03 · Procter →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.